Successful osimertinib rechallenge in a patient with advanced non-small cell lung cancer following osimertinib-induced interstitial lung disease after treatment with nivolumab.
作者信息
Mamesaya Nobuaki, Kenmotsu Hirotsugu, Takahashi Toshiaki
机构信息
Division of Thoracic Oncology, Shizuoka Cancer Center Hospital, 1007 Shimonagakubo, Nagaizumi-cho, Sunto-gun, Shizuoka, 411-8777, Japan.
出版信息
Invest New Drugs. 2017 Dec;35(6):839-841. doi: 10.1007/s10637-017-0471-y. Epub 2017 May 2.
Abstract
摘要
Zotero 插件